Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer

Blair, HA

Blair, HA (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

TARGETED ONCOLOGY, 2018; 13 (3): 399

Abstract

Atezolizumab (TECENTRIQ (TM)), an immune checkpoint inhibitor, is an immunoglobulin G1 monoclonal antibody that binds to programmed death ligand 1 (PD......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索